HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $8 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.2%

Neg 0% Neu 87.2% Pos 0%

HC Wainwright & Co. analyst Brandon Folkes reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains $8 price target.